Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.16 USD | -1.88% |
|
+10.50% | -1.73% |
06-17 | Zymeworks Says FDA Clears Investigational New Drug Application for Cancer Therapy | MT |
06-17 | Zymeworks Gets FDA OK to Study ZW171 for Mesothelin-Expressing Cancers | DJ |
- Stock Market
- Equities
- ZYME Stock
- Charts Zymeworks Inc.
- Static Chart